Development of a Highly Sensitive Method Using Liquid Chromatography-Multiple Reaction Monitoring to Quantify Membrane P-Glycoprotein in Biological Matrices and Relationship to Transport Function
暂无分享,去创建一个
[1] A. Ungell,et al. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[2] Michael B. Bolger,et al. Simulations of the Nonlinear Dose Dependence for Substrates of Influx and Efflux Transporters in the Human Intestine , 2009, The AAPS Journal.
[3] Tetsuya Terasaki,et al. Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria , 2008, Pharmaceutical Research.
[4] Caroline A. Lee,et al. Drug–Drug Interactions Mediated Through P‐Glycoprotein: Clinical Relevance and In Vitro–In Vivo Correlation Using Digoxin as a Probe Drug , 2009, Clinical pharmacology and therapeutics.
[5] Na Li,et al. LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species. , 2009, Analytical chemistry.
[6] H. Glaeser,et al. P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans , 2003, Clinical pharmacology and therapeutics.
[7] Jiunn H. Lin,et al. Role of P-Glycoprotein in Pharmacokinetics , 2003, Clinical pharmacokinetics.
[8] Tetsuya Terasaki,et al. Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection. , 2011, Journal of pharmaceutical sciences.
[9] Paul W Brown,et al. Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples. , 2011, Rapid communications in mass spectrometry : RCM.
[10] Zhonggui He,et al. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[11] Y. Lai,et al. Absolute quantification of multidrug resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometry. , 2008, Analytical biochemistry.
[12] S. Carr,et al. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? , 2008, Clinical chemistry.
[13] F. Pontén,et al. Towards a human proteome atlas: High‐throughput generation of mono‐specific antibodies for tissue profiling , 2005, Proteomics.
[14] Caroline A. Lee,et al. P-glycoprotein related drug interactions: clinical importance and a consideration of disease states , 2010, Expert opinion on drug metabolism & toxicology.
[15] Bo Feng,et al. Refining the in vitro and in vivo critical parameters for P-glycoprotein, [I]/IC50 and [I2]/IC50, that allow for the exclusion of drug candidates from clinical digoxin interaction studies. , 2010, Molecular pharmaceutics.
[16] T. Andersson,et al. High-Activity P-Glycoprotein, Multidrug Resistance Protein 2, and Breast Cancer Resistance Protein Membrane Vesicles Prepared from Transiently Transfected Human Embryonic Kidney 293-Epstein-Barr Virus Nuclear Antigen Cells , 2010, Drug Metabolism and Disposition.
[17] Ruedi Aebersold,et al. Mass spectrometry based targeted protein quantification: methods and applications. , 2009, Journal of proteome research.
[18] D. Russell,et al. Proteolysis in mixed organic-aqueous solvent systems: applications for peptide mass mapping using mass spectrometry. , 2001, Analytical chemistry.
[19] Darryl B. Hardie,et al. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). , 2004, Journal of proteome research.
[20] Alan L Rockwood,et al. Liquid Chromatography Tandem Mass Spectrometry in Clinical , 2012 .
[21] John C Lipscomb,et al. Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. , 2007, Current drug metabolism.
[22] Y. Lai,et al. Absolute Difference of Hepatobiliary Transporter Multidrug Resistance-Associated Protein (MRP2/Mrp2) in Liver Tissues and Isolated Hepatocytes from Rat, Dog, Monkey, and Human , 2009, Drug Metabolism and Disposition.
[23] S. Gygi,et al. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] U. Hofmann,et al. Increased Absorption of Digoxin from the Human Jejunum Due to Inhibition of Intestinal Transporter-Mediated Efflux , 2007, Clinical pharmacokinetics.